Patent · US Active

Methods of lowering blood glucose levels in a mammal

US10517901B2 · kind B2 · utility

2Cited by
32References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2018
Grant dateDec 31, 2019
Priority date
Expiry dateApr 24, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods of producing pancreatic hormone-expressing cells by first differentiating pluripotent cells in cell culture so as to produce endodermal cells, the endodermal cells being competent to further differentiate into hormone-expressing cells capable of secreting at least one pancreatic hormone in response to a physiological signal, and then, transplanting the cultured endodermal cells into an organism, such as an organism in need of an endocrine cell therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.